Although there are few data regarding children and adolescents, patch technology does appear to improve adherence to treatment in a range of patient populations 6 8. Longterm safety, efficacy, and patient acceptability of the tulobuterol. Tulobuterol patch hokunalintm tape, which contains a. Addition of transdermal or inhaled longacting beta2agonists in adult asthmatic.
Hokunalintape is a longacting transdermal b2 agonist, developed by abbott japan and nitto denko corporation, marketed by abbott japan and maruho. Tamura and ohta reported higher treatment compliance with the tulobuterol patch, a transdermal longacting. The patients applied a tulobuterol patch 2 mg every 24 hours for 4 weeks followed by inhalation of salmeterol 100. It relies on a matrixtype transdermal delivery system that contains both. Tulobuterol patch hokunalin tape, which contains a.
Hokunalin tape tulobuterol patch, a longacting transdermal bronchodilator,is now in new packages printed with the content on the tape. Tulobuterol inn is a longacting beta2adrenergic receptor agonist, marketed in japan as a transdermal patch under the name hokunalin tape. Hokunalin tape tulobuterol patch, the worlds first longacting transdermal bronchodilator, will include printing of hokunalin on the tape surface. Nitto europe hokunalin tape tulobuterol patch, a long. Consult your doctor or pharmacist if you have any questions.
Tulobuterol has almost no effects on blood pressure and heart rate and is highly selective for the tracheal muscle. It indicated for the treatment of relief of various symptoms, such as dyspnea, resulting from airway obstruction in bronchial asthma, acute bronchitis, chronic bronchitis, and pulmonary emphysema. The tulobuterol patch hokunalin is a transdermal patch preparation of the beta2adrenoceptor agonist beta2agonist tulobuterol designed to yield sustained beta2agonistic effects for 24. Addition of transdermal or inhaled longacting beta2agonists in adult asthmatic patients treated with inhaled corticosteroids. Read the patient information leaflet available from your pharmacist. Japan, germany, china, south korea, bangladesh, pakistan, and venezuela. Transdermal therapy for attentiondeficit hyperactivity. Tulobuterol is a longacting beta2adrenergic receptor agonist.
1398 1176 1103 317 1368 105 445 1207 993 61 281 1030 783 803 421 699 278 1258 462 1462 1406 1424 1192 663 1251 1072 1004 1180 1159 270 798 1406 306 1011 1232 121 1168 611 1300 1050 939 1132 274 1082 1240 224 599 1363